contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


indutrade-makes-add-on-acquisition-within-medtech

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Indutrade operates in the trading and manufacturing industry and focuses on the sale and distribution of components and systems for various industries. The company's products are aimed at companies in sectors such as energy, automotive and medical technology. The business is global with a main presence in Sweden, the UK &amp; Ireland, Benelux and Denmark. Indutrade was founded in 1978 and is headquartered in Stockholm.

Indutrade

Indutrade has signed an agreement to acquire the Polish company Optimed Pro-Office, www.optimedpro-office.eu, with annual sales of approximately PLN 14 million (SEK 35 million).Optimed is a ...

<div class="mfn-preamble"><p><strong>Indutrade has signed an agreement to acquire the Polish company Optimed Pro-Office, </strong><strong><a rel="noopener" href="http://www.optimedpro-office.eu/">www.optimedpro-office.eu</a></strong><strong>, with annual sales of approximately PLN 14 million (SEK 35 million).</strong></p></div><div class="mfn-body"><p>Optimed is a technical trading company offering disposables and medical equipment to hospitals and care providers in Poland. The company specialises in interventional cardiology, oncology, surgery, and anesthesiology, with an offering including instruments for blood flow restoration, tissue ablation systems, vascular ports, vascular catheters, and laser equipment, among others. Optimed was founded in 1996, has seven employees and is located in Krakow, Poland.</p><p>As an add-on to Indutrade-owned CIRRO in Poland, the companies’ combined offerings will provide good growth opportunities.</p><p>The closing took place on 30 July and Optimed will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's sixth in 2025 and is expected to have a marginally positive impact on Indutrade's earnings per share.</p></div><div class="mfn-footer mfn-contacts mfn-57685104bc40"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Bo Annvik, President and CEO<br>Phone +46 8 703 03 00</p></div><div class="mfn-footer mfn-about mfn-11bd2624e872"><p><strong class="mfn-heading-1">About Indutrade</strong><br><em>Indutrade is an international technology and industrial business group that today consists of over 200 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 32.5 billion in 2024, and the share is listed on Nasdaq Stockholm in Sweden.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/e10e274f-9f50-4aaa-bc09-24a788eec319/indutrade-makes-add-on-acquisition-within-medtech.pdf" class="mfn-generated mfn-primary">Indutrade makes add-on acquisition within medtech</a></p></div>